Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
figure
posted on 2021-03-16, 12:09 authored by Adis journals on behalf of, Shun Lu, Jin-Yuan Shih, Tae-Won Jang, Chong-Kin Liam, Yongfeng Yu<p><strong>Article full
text</strong></p>
<p><br>
The above summary slide and plain language summary represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
History
Related Materials
- 1.
- 2.
